[Skip to content]

Public Finance International
News and comment on global public financial management
.

UK invests £138m in PPPs to tackle disease

By Mark Smulian | 23 August 2013

The UK is to invest in public-private partnerships set up to combat fatal diseases in the developing world.

Its Department for International Development is investing £138m over the next five years in nine partnerships to support the development of new drugs, vaccines, insecticides, diagnostic tools and microbicides to prevent, diagnose or treat diseases.

Diseases to be targeted include HIV, tuberculosis, malaria, diarrhoea and ‘neglected’ tropical diseases where there are either no treatments available, or they are difficult to use, or where infections have become resistant to existing drugs.

According to the DFID, each year 800,000 children die of diarrhoea; 660,000 people die of malaria – most of them children – 1.4 million die of tuberculosis and more than 1 million people have a ‘neglected’ tropical disease such as sleeping sickness, skin sores and worm conditions.

Many pharmaceutical companies have, despite this, been reluctant to research and develop new products in these cases because of the small financial returns, the department said.

UK International Development Secretary Justine Greening said: ‘The development of new technologies is vital if we are to improve the health of the poorest people through better treatment and prevention and avoid the unnecessary deaths of children.

‘Working together in product development partnerships, the public and private sectors have a chance to bring together their expertise for the benefit of millions of the world’s poorest and most vulnerable people.’

The nine product development partnerships supported by the DFID are:

•    Drugs for Neglected Diseases initiative.

•    Medicines for Malaria Venture.

•    Innovative Vector Control Consortium.

•    Foundation for Innovative New Diagnostics.

•    TB Alliance.

•    Aeras (new TB vaccines)

•    New Products for Diarrhoea and Malaria.

•    International AIDS Vaccine Initiative.

•    International Partnership for Microbicides.


Spacer

Share this article here:


Weekly news update

Email icon

Get international news delivered straight to your inbox

Sign up for the Public Finance International weekly newsletter

Blog

  • A Bund-buying spree for the ECB?
    A European Central Bank programme of Quantitative Easing based on German government bonds would be a useful move. It would help to eliminate structural imbalances and push up...
  • Spain: a question of control
    The role of the controller within Spanish government has recently been enhanced by new legislation. Hopes are high that this will improve accountability and independence at...
  • Banks, bonuses and balance sheets
    IMF research shows the high level of subsidies paid to banks deemed too important to fail. Until the political will to take on the industry is found, we will effectively each...

Configure your Portal

Public Finance International is created in partnership with:

CIPFA logo
Public Finance logo
Twitter feed